Pharmaceuticals

Hepatitis C drug may be effective in treatment of Zika-infected adults: study

27 Jan 2018

Celgene to buy experimental gene therapy cancer drug maker Juno Therapeutics for $9 bn

25 Jan 2018

China’s Sinocare in talks to buy J&J’s diabetes care units worth around $4 bn

24 Jan 2018

Sanofi in pact to acquire US biotech haemophila drugs maker Bioverativ for 11.6 bn

22 Jan 2018

Biocon, Sandoz ink global pact for immunology, oncology biosimilar

19 Jan 2018

Both companies will share responsibility for end-to-end development, manufacturing and global regulatory approvals for a number of products and will have a cost and profit share arrangement globally

Pfizer to end Alzheimer, Parkinson research; patients disappointed

17 Jan 2018

Celgene Corp in talks to buy Juno Therapeutics

17 Jan 2018

In urban streams, pharmaceutical pollution is driving microbial resistance

11 Jan 2018

Pfizer to end research to develop new drugs for Alzheimer’s and Parkinson’s disease

09 Jan 2018

Celgene to Acquire Impact Biomedicines for upto $7 bn

08 Jan 2018

Luxturna gene therapy to cure rare blindness

05 Jan 2018

Bharat Biotech scores big with WHO-approved typhoid vaccine

04 Jan 2018

Typbar TCV, a fourth generation vaccine against typhoid disease, has proven to provide long term protection against typhoid to both adults and children below 2 years of age

Price of cancer drug Lomustine hiked 1400 per cent since 2013

29 Dec 2017

Martin Shkreli’s former company lawyer convicted for fraud

28 Dec 2017

Opioid crisis hits US life expectancy

23 Dec 2017

N Carolina sues pharma company over opioid marketing campaign

22 Dec 2017

Roche to acquire US biotech firm Ignyta for $1.7 billion

22 Dec 2017

Indian firm gets regulator’s nod to start Zika vaccine trials

19 Dec 2017

Drugmaker Sanofi under fire over Dengvaxia reverse

18 Dec 2017

US pharma industry challenges California's transparency legislation

09 Dec 2017

Stryker Corp to buy Entellus Medical for $662 mn

08 Dec 2017

Gilead Sciences to buy Cell Design Labs for up to $567 mn

08 Dec 2017

Walgreens' Boots Alliance buys 40% in Sinopharm Holding GuoDa Drugstores for $418 mn

07 Dec 2017

Nestle to buy Canadian vitamin maker Atrium for $2.3 bn

07 Dec 2017

Swiss food and drink giant Nestle SA yesterday struck a deal to buy Canadian privately-held vitamin maker Atrium Innovations for $2.3 billion in order to expand its consumer healthcare portfolio

Over 10% of medical products spurious; poor nations worst hit: WHO

06 Dec 2017